Literature DB >> 12941928

Dephosphorylation of eIF-2alpha mediated by the gamma(1)34.5 protein of herpes simplex virus type 1 is required for viral response to interferon but is not sufficient for efficient viral replication.

Guofeng Cheng1, Kui Yang, Bin He.   

Abstract

The gamma(1)34.5 protein of herpes simplex virus type 1 (HSV-1) functions to block the shutoff of protein synthesis involving double-stranded RNA-dependent protein kinase (PKR). In this process, the gamma(1)34.5 protein recruits cellular protein phosphatase 1 (PP1) to form a high-molecular-weight complex that dephosphorylates eIF-2alpha. Here we show that the gamma(1)34.5 protein is capable of mediating eIF-2alpha dephosphorylation without any other viral proteins. While deletion of amino acids 1 to 52 from the gamma(1)34.5 protein has no effect on eIF-2alpha dephosphorylation, further truncations up to amino acid 146 dramatically reduce the activity of the gamma(1)34.5 protein. An additional truncation up to amino acid 188 is deleterious, indicating that the carboxyl-terminal domain alone is not functional. Like wild-type HSV-1, the gamma(1)34.5 mutant with a truncation of amino acids 1 to 52 is resistant to interferon, and resistance to interferon is coupled to eIF-2alpha dephosphorylation. Intriguingly, this mutant exhibits a similar growth defect seen for the gamma(1)34.5 null mutant in infected cells. Restoration of the wild-type gamma(1)34.5 gene in the recombinant completely reverses the phenotype. These results indicate that eIF-2alpha dephosphorylation mediated by the gamma(1)34.5 protein is required for HSV response to interferon but is not sufficient for viral replication. Additional functions or activities of the gamma(1)34.5 protein contribute to efficient viral infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941928      PMCID: PMC224583          DOI: 10.1128/jvi.77.18.10154-10161.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals.

Authors:  I Mohr; D Sternberg; S Ward; D Leib; M Mulvey; Y Gluzman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Val193 and Phe195 of the gamma 1 34.5 protein of herpes simplex virus 1 are required for viral resistance to interferon-alpha/beta.

Authors:  G Cheng; M E Brett; B He
Journal:  Virology       Date:  2001-11-10       Impact factor: 3.616

3.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

4.  DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein. Primary structure and homology with protein phosphatase inhibitor-1.

Authors:  K R Williams; H C Hemmings; M B LoPresti; W H Konigsberg; P Greengard
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

5.  An N-terminal arginine-rich cluster and a proline-alanine-threonine repeat region determine the cellular localization of the herpes simplex virus type 1 ICP34.5 protein and its ligand, protein phosphatase 1.

Authors:  Hanwen Mao; Kenneth S Rosenthal
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

6.  AlaArg motif in the carboxyl terminus of the gamma(1)34.5 protein of herpes simplex virus type 1 is required for the formation of a high-molecular-weight complex that dephosphorylates eIF-2alpha.

Authors:  G Cheng; M Gross; M E Brett; B He
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.

Authors:  F Farassati; A D Yang; P W Lee
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

8.  Interaction between growth arrest-DNA damage protein 34 and Src kinase Lyn negatively regulates genotoxic apoptosis.

Authors:  A V Grishin; O Azhipa; I Semenov; S J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 9.  Protein phosphatase 1--targeted in many directions.

Authors:  Patricia T W Cohen
Journal:  J Cell Sci       Date:  2002-01-15       Impact factor: 5.285

10.  Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha.

Authors:  I Novoa; H Zeng; H P Harding; D Ron
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

View more
  30 in total

1.  Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and gamma(1)34.5 gene products.

Authors:  Matthew Mulvey; Vladimir Camarena; Ian Mohr
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

3.  Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1.

Authors:  Zachary M Parker; Aisling A Murphy; David A Leib
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

4.  The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.

Authors:  Zongdi Feng; Melissa Cerveny; Zhipeng Yan; Bin He
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

5.  Herpes simplex virus 2 infection impacts stress granule accumulation.

Authors:  Renée L Finnen; Kyle R Pangka; Bruce W Banfield
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.

Authors:  Ryuichi Kanai; Cecile Zaupa; Donatella Sgubin; Slawomir J Antoszczyk; Robert L Martuza; Hiroaki Wakimoto; Samuel D Rabkin
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

7.  Herpes simplex virus 1 infection activates the endoplasmic reticulum resident kinase PERK and mediates eIF-2alpha dephosphorylation by the gamma(1)34.5 protein.

Authors:  Guofeng Cheng; Zongdi Feng; Bin He
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  Role of Herpes Simplex Virus 1 γ34.5 in the Regulation of IRF3 Signaling.

Authors:  Richard Manivanh; Jesse Mehrbach; David M Knipe; David A Leib
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  Herpes simplex virus 2 expresses a novel form of ICP34.5, a major viral neurovirulence factor, through regulated alternative splicing.

Authors:  Shuang Tang; Nini Guo; Amita Patel; Philip R Krause
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

Review 10.  Intrinsic cellular defenses against virus infection by antiviral type I interferon.

Authors:  Kyung-Hyun Boo; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.